Epigral

{
  "main_header": {
    "sid": 1003523,
    "name": "Epigral",
    "stock_name": "Epigral",
    "full_name": "Epigral Ltd",
    "name_url": "stocks-analysis/epigral",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "1,101.05",
    "chg": -5.25,
    "chgp": "-0.47%",
    "dir": -1,
    "prev_price": "1,106.30",
    "mcapval": "4,750.08 Cr",
    "mcap": "Small Cap",
    "scripcode": 543332,
    "symbol": "EPIGRAL",
    "ind_name": "Specialty Chemicals",
    "ind_code": 11,
    "sector_id": 74,
    "indexname": "India SENSEX",
    "isin": "INE071N01016",
    "curr_date": "Jul 31, 12:56 PM",
    "curr_time": "12:57 PM",
    "last_traded_at": "Jul 31, 12:56 PM IST",
    "bse_nse_vol": "16.55 k",
    "exc_status": "Active",
    "traded_date": "Jul 31, 2026",
    "traded_date_str": "2026 07 31",
    "score": "",
    "scoreText": "",
    "Live": 1,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/epigral-1003523-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Epigral Ltd Technical Momentum Shifts Amid Bearish Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/epigral-ltd-technical-momentum-shifts-amid-bearish-signals-4129587",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/EpigralLtd_technicaldot_4129587.png",
        "date": "2026-07-31 08:02:52",
        "description": "Epigral Ltd, a small-cap player in the specialty chemicals sector, has experienced a notable shift in its technical momentum, signalling increased bearish pressure. Despite a modest recovery in monthly MACD readings, the overall technical landscape remains challenging, with key indicators such as moving averages and KST pointing to sustained downward trends. This analysis delves into the recent technical parameter changes, price momentum, and comparative performance against the Sensex to provide a comprehensive view for investors."
      },
      {
        "title": "Epigral Ltd Valuation Shifts: From Attractive to Fair Amid Specialty Chemicals Sector Dynamics",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/epigral-ltd-valuation-shifts-from-attractive-to-fair-amid-specialty-chemicals-sector-dynamics-4125080",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/EpigralLtd_valuationdot_4125080.png",
        "date": "2026-07-29 08:02:20",
        "description": "Epigral Ltd, a small-cap player in the Specialty Chemicals sector, has witnessed a notable shift in its valuation parameters, moving from a very attractive to a fair valuation grade. This change reflects evolving market perceptions amid sector-wide valuation disparities and company-specific performance metrics, prompting investors to reassess the stock’s price attractiveness relative to its peers and historical benchmarks."
      },
      {
        "title": "Are Epigral Ltd latest results good or bad?",
        "link": "https://www.marketsmojo.com/news/result-analysis/are-epigral-ltd-latest-results-good-or-bad-4124646",
        "imagepath": "",
        "date": "2026-07-28 19:18:25",
        "description": "Epigral Ltd's latest financial results for the quarter ending June 2026 reflect a complex operational landscape characterized by both sequential recovery and year-on-year challenges. The company reported net sales of ₹705.36 crores, which represents a decline of 4.18% compared to the previous quarter, breaking the momentum seen in the prior quarter's strong growth. However, year-on-year, net sales showed a notable increase of 16.29%, indicating some resilience in demand compared to the same period last year.\n\nThe net profit for the quarter was ₹99.74 crores, which marked a sequential increase of 23.21% from the previous quarter, showcasing a recovery in profitability. Nonetheless, on a year-on-year basis, net profit experienced a decline of 37.93%, largely influenced by an exceptionally strong profit base in the prior year due to tax adjustments.\n\nOperating margins improved significantly, expanding to 25.41..."
      },
      {
        "title": "Epigral Ltd is Rated Sell by MarketsMOJO",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/epigral-ltd-is-rated-sell-by-marketsmojo-4124207",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/EpigralLtd_mojoScore_4124207.png",
        "date": "2026-07-28 10:10:03",
        "description": "Epigral Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 26 Dec 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 28 July 2026, providing investors with an up-to-date view of the company’s performance and outlook."
      },
      {
        "title": "Epigral Ltd Reports Stabilised Quarterly Performance Amid Mixed Financial Indicators",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/epigral-ltd-reports-stabilised-quarterly-performance-amid-mixed-financial-indicators-4123098",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/EpigralLtd_fintrenddot_4123098.png",
        "date": "2026-07-28 08:00:12",
        "description": "Epigral Ltd, a small-cap player in the Specialty Chemicals sector, has reported a stabilisation in its financial trend for the quarter ended June 2026, shifting from a negative trajectory to a flat performance. Despite some encouraging signs in operating profit and quarterly earnings growth, the company continues to face challenges in return on capital and cash reserves, reflecting a mixed outlook for investors."
      },
      {
        "title": "Epigral Q1 FY27: Profit Rebounds 23% Despite Revenue Dip and Margin Pressures",
        "link": "https://www.marketsmojo.com/news/result-analysis/epigral-q1-fy27-profit-rebounds-23-despite-revenue-dip-and-margin-pressures-4123000",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/Epigral_quaterlyResult_4123000.png",
        "date": "2026-07-27 20:47:10",
        "description": "Epigral Ltd., a specialty chemicals manufacturer with a market capitalisation of ₹5,088 crores, reported a mixed performance in Q1 FY27, with consolidated net profit rising 23.21% quarter-on-quarter to ₹99.74 crores despite a 4.18% decline in net sales. The company's shares traded at ₹1,159.75 on July 27, down 37.28% over the past year, significantly underperforming the broader Sensex and the specialty chemicals sector."
      },
      {
        "title": "Are Epigral Ltd latest results good or bad?",
        "link": "https://www.marketsmojo.com/news/result-analysis/are-epigral-ltd-latest-results-good-or-bad-4122961",
        "imagepath": "",
        "date": "2026-07-27 19:13:34",
        "description": "Epigral Ltd's latest financial results present a complex picture of the company's performance. In the quarter ending March 2026, Epigral achieved record net sales of ₹736.16 crores, reflecting a 23.29% sequential increase and a 17.29% rise year-on-year. However, the operating margin contracted to 22.90%, down from 27.62% in the same quarter last year, indicating significant operational challenges despite the revenue growth.\n\nThe consolidated net profit for Q4 FY26 was ₹80.95 crores, which marked a substantial 106.98% increase compared to the previous quarter but represented a 6.84% decline year-on-year. This profit surge was primarily influenced by a one-time tax benefit in the prior quarter, which complicates the comparison and highlights underlying profitability issues.\n\nIn the subsequent quarter ending June 2026, the company reported a decline in net sales of 4.18% from the previous quarter, with net pro..."
      },
      {
        "title": "Epigral Ltd Gains 10.66%: Two Key Technical Shifts Drive Weekly Rally",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/epigral-ltd-gains-1066-two-key-technical-shifts-drive-weekly-rally-4120377",
        "imagepath": "",
        "date": "2026-07-25 11:03:08",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>20 Jul:</strong> Stock opens week at Rs.1,083.30 with 3.07% gain</p>\n                    <p><strong>21 Jul:</strong> Intraday high of Rs.1,170.95 with 7.08% surge</p>\n                    <p><strong>22 Jul:</strong> Technical momentum shifts amid mixed signals</p>\n                    <p><strong>24 Jul:</strong> Week closes at Rs.1,163.05, up 10.66% for the week</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\">\n                        <div class=\"stat-label\">Week Open</div>\n                        <div class=\"stat-value\">Rs.1,051.05</div>\n                    </div>\n                    <div class=\"stat-item\">\n             ..."
      },
      {
        "title": "When is the next results date for Epigral Ltd?",
        "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-epigral-ltd-4118349",
        "imagepath": "",
        "date": "2026-07-23 23:17:13",
        "description": "The next results date for Epigral Ltd is scheduled for 27 July 2026...."
      }
    ],
    "total": 636,
    "sid": "1003523",
    "stock_news_url": "https://www.marketsmojo.com/news/epigral-1003523"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "29-Jul-2026",
      "details": "Newpaper Publication - Un-Audited Financial Results for the First Quarter ended 30.06.2026",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
      "datetime": "27-Jul-2026",
      "details": "Investor Presentation Q1 FY 27.",
      "source": "BSE"
    },
    {
      "caption": "Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 (SEBI Listing Regulations) - Outcome Of Board Meeting",
      "datetime": "27-Jul-2026",
      "details": "As part of the Companys strategic growth and expansion initiatives it proposes to establish a new manufacturing facility for Epoxy Resin and formulations and Multi Purpose Plant at its existing facility at Dahej Gujarat.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Epigral Ltd has declared <strong>50%</strong> dividend, ex-date: 01 Jun 26",
          "dt": "2026-06-01",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Epigral Ltd Technical Momentum Shifts Amid Bearish Signals

2026-07-31 08:02:52

Epigral Ltd, a small-cap player in the specialty chemicals sector, has experienced a notable shift in its technical momentum, signalling increased bearish pressure. Despite a modest recovery in monthly MACD readings, the overall technical landscape remains challenging, with key indicators such as moving averages and KST pointing to sustained downward trends. This analysis delves into the recent technical parameter changes, price momentum, and comparative performance against the Sensex to provide a comprehensive view for investors.

Read full news article

Epigral Ltd Valuation Shifts: From Attractive to Fair Amid Specialty Chemicals Sector Dynamics

2026-07-29 08:02:20

Epigral Ltd, a small-cap player in the Specialty Chemicals sector, has witnessed a notable shift in its valuation parameters, moving from a very attractive to a fair valuation grade. This change reflects evolving market perceptions amid sector-wide valuation disparities and company-specific performance metrics, prompting investors to reassess the stock’s price attractiveness relative to its peers and historical benchmarks.

Read full news article

Are Epigral Ltd latest results good or bad?

2026-07-28 19:18:25

Epigral Ltd's latest financial results for the quarter ending June 2026 reflect a complex operational landscape characterized by both sequential recovery and year-on-year challenges. The company reported net sales of ₹705.36 crores, which represents a decline of 4.18% compared to the previous quarter, breaking the momentum seen in the prior quarter's strong growth. However, year-on-year, net sales showed a notable increase of 16.29%, indicating some resilience in demand compared to the same period last year. The net profit for the quarter was ₹99.74 crores, which marked a sequential increase of 23.21% from the previous quarter, showcasing a recovery in profitability. Nonetheless, on a year-on-year basis, net profit experienced a decline of 37.93%, largely influenced by an exceptionally strong profit base in the prior year due to tax adjustments. Operating margins improved significantly, expanding to 25.41...

Read full news article

Epigral Ltd is Rated Sell by MarketsMOJO

2026-07-28 10:10:03

Epigral Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 26 Dec 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 28 July 2026, providing investors with an up-to-date view of the company’s performance and outlook.

Read full news article

Epigral Ltd Reports Stabilised Quarterly Performance Amid Mixed Financial Indicators

2026-07-28 08:00:12

Epigral Ltd, a small-cap player in the Specialty Chemicals sector, has reported a stabilisation in its financial trend for the quarter ended June 2026, shifting from a negative trajectory to a flat performance. Despite some encouraging signs in operating profit and quarterly earnings growth, the company continues to face challenges in return on capital and cash reserves, reflecting a mixed outlook for investors.

Read full news article

Epigral Q1 FY27: Profit Rebounds 23% Despite Revenue Dip and Margin Pressures

2026-07-27 20:47:10

Epigral Ltd., a specialty chemicals manufacturer with a market capitalisation of ₹5,088 crores, reported a mixed performance in Q1 FY27, with consolidated net profit rising 23.21% quarter-on-quarter to ₹99.74 crores despite a 4.18% decline in net sales. The company's shares traded at ₹1,159.75 on July 27, down 37.28% over the past year, significantly underperforming the broader Sensex and the specialty chemicals sector.

Read full news article

Are Epigral Ltd latest results good or bad?

2026-07-27 19:13:34

Epigral Ltd's latest financial results present a complex picture of the company's performance. In the quarter ending March 2026, Epigral achieved record net sales of ₹736.16 crores, reflecting a 23.29% sequential increase and a 17.29% rise year-on-year. However, the operating margin contracted to 22.90%, down from 27.62% in the same quarter last year, indicating significant operational challenges despite the revenue growth. The consolidated net profit for Q4 FY26 was ₹80.95 crores, which marked a substantial 106.98% increase compared to the previous quarter but represented a 6.84% decline year-on-year. This profit surge was primarily influenced by a one-time tax benefit in the prior quarter, which complicates the comparison and highlights underlying profitability issues. In the subsequent quarter ending June 2026, the company reported a decline in net sales of 4.18% from the previous quarter, with net pro...

Read full news article

Epigral Ltd Gains 10.66%: Two Key Technical Shifts Drive Weekly Rally

2026-07-25 11:03:08

Key Events This Week

20 Jul: Stock opens week at Rs.1,083.30 with 3.07% gain

21 Jul: Intraday high of Rs.1,170.95 with 7.08% surge

22 Jul: Technical momentum shifts amid mixed signals

24 Jul: Week closes at Rs.1,163.05, up 10.66% for the week

Week Open

Rs.1,051.05

...

Read full news article

When is the next results date for Epigral Ltd?

2026-07-23 23:17:13

The next results date for Epigral Ltd is scheduled for 27 July 2026....

Read full news article

View All News